《中国康复理论与实践》 ›› 2020, Vol. 26 ›› Issue (3): 325-329.doi: 10.3969/j.issn.1006-9771.2020.03.012
收稿日期:
2019-07-11
修回日期:
2019-09-23
出版日期:
2020-03-25
发布日期:
2020-04-01
通讯作者:
陶静
E-mail:taojing01@fjtcm.edu.cn
作者简介:
张嘉泳(1994-),女,汉族,广东广州市人,硕士研究生,主要研究方向:神经康复与认知科学研究。|陶静,女,汉族,博士,教授,博士研究生导师,主要研究方向:神经康复与认知科学研究。
基金资助:
ZHANG Jia-yong1,2,LIU Wei-lin1,2,CHEN Li-dian1,TAO Jing1()
Received:
2019-07-11
Revised:
2019-09-23
Published:
2020-03-25
Online:
2020-04-01
Contact:
TAO Jing
E-mail:taojing01@fjtcm.edu.cn
Supported by:
摘要:
神经颗粒素(Ng)是一种神经元特异性突触后蛋白,大量存在于大脑皮质和海马等部位,主要通过磷酸化反应和氧化还原作用改变与钙调蛋白的亲和力,并通过谷氨酸受体依赖方式参与钙信号传导途径,实现神经元间信息传导调控和突触可塑性调节。Ng在相关脑区参与记忆的形成和编码,在学习记忆和认知功能中发挥重要作用。Ng与阿尔茨海默病的认知功能下降有关,并可作为诊断阿尔茨海默病的突触生物标志物;脑卒中后认知功能障碍与大脑Ng表达减少有关;Ng还是精神分裂症易感性相关的基因变异之一。
中图分类号:
张嘉泳,柳维林,陈立典,陶静. 神经颗粒素对中枢神经系统疾病认知功能障碍作用的研究进展[J]. 《中国康复理论与实践》, 2020, 26(3): 325-329.
ZHANG Jia-yong,LIU Wei-lin,CHEN Li-dian,TAO Jing. Advance in Neurogranin for Cognitive Impairment Second to Central Nervous System Diseases (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2020, 26(3): 325-329.
[1] |
Represa A, Deloulme J, Sensenbrenner M, et al. Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate[J]. J Neurosci, 1990, 10(12):3782-3792.
pmid: 2269883 |
[2] |
Baudier J, Deloulme J, Dorsselaer A, et al. Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). Identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain[J]. J Biol Chem, 1991, 266(1):229-237.
pmid: 1824695 |
[3] |
Houbre D, Duportail G, Deloulme J, et al. The interactions of the brain-specific calmodulin-binding protein kinase C substrate, neuromodulin (GAP 43), with membrane phospholipids[J]. J Biol Chem, 1991, 266(11):7121-7131.
pmid: 1826685 |
[4] |
Petersen A, Gerges N. Neurogranin regulates CaM dynamics at dendritic spines[J]. Sci Rep, 2015, 5(1):11135-11144.
doi: 10.1038/srep11135 |
[5] |
Singec I, Knoth R, Ditter M, et al. Neurogranin is expressed by principal cells but not interneurons in the rodent and monkey neocortex and hippocampus[J]. J Comp Neurol, 2010, 479(1):30-42.
doi: 10.1002/(ISSN)1096-9861 |
[6] |
Watson J, Battenberg E, Wong K, et al. Subtractive cDNA cloning of RC3, a rodent cortex-enriched mRNA encoding a novel 78 residue protein[J]. J Neurosci Res, 1990, 26(4):397-408.
pmid: 2231781 |
[7] |
Mruk K, Farley B, Ritacco A, et al. Calmodulation meta-analysis: predicting calmodulin binding via canonical motif clustering[J]. J Gen Physiol, 2014, 144(1):105-114.
doi: 10.1085/jgp.201311140 |
[8] |
Kumar V, Chichili V, Zhong L, et al. Structural basis for the interaction of unstructured neuron specific substrates neuromodulin and neurogranin with calmodulin[J]. Sci Rep, 2013, 3(3):1392-1346.
doi: 10.1038/srep01392 |
[9] |
Domínguezgonzález I, Vázquezcuesta S, Algaba A, et al. Neurogranin binds to phosphatidic acid and associates to cellular membranes[J]. Biochem J, 2007, 404(1):31-43.
doi: 10.1042/BJ20061483 |
[10] |
Zhong L, Kaleka K, Gerges N. Neurogranin phosphorylation fine-tunes long-term potentiation[J]. Eur J Neurosci, 2011, 33(2):244-250.
doi: 10.1111/j.1460-9568.2010.07506.x |
[11] |
Huang K, Huang F. Calcium-sensitive translocation of calmodulin and neurogranin between soma and dendrites of mouse hippocampal CA1 neurons[J]. ACS Chem Neurosci, 2011, 2(4):223-230.
doi: 10.1021/cn200003f |
[12] |
Ramakers G, Gerendasy D, de Graan P N. Substrate phosphorylation in the protein kinase Cγ knockout mouse[J]. J Biol Chem, 1999, 274(4):1873-1874.
pmid: 9890937 |
[13] | Seeger C, Talibov V, Danielson U. Biophysical analysis of the dynamics of calmodulin interactions with neurogranin and Ca2+/calmodulin-dependent kinase II[J]. J Mol Recognit, 2017, 30(8):e2621. |
[14] |
Zhong L, Cherry T, Bies C, et al. Neurogranin enhances synaptic strength through its interaction with calmodulin[J]. EMBO J, 2009, 28(4):3027-3039.
doi: 10.1038/emboj.2009.236 |
[15] |
Li J, Pak J, Huang F, et al. N-methyl-D-aspartate induces neurogranin/RC3 oxidation in rat brain slices[J]. J Biol Chem, 1999, 274(3):1294-1366.
pmid: 9880498 |
[16] |
Huang K P, Huang F L, Li J, et al. Calcium-sensitive interaction between calmodulin and modified forms of rat brain neurogranin/RC3[J]. Biochemistry, 2000, 39(24):7291-7299.
doi: 10.1021/bi000336l |
[17] |
Jones K, Templet S, Zemoura K, et al. Rapid, experience-dependent translation of neurogranin enables memory encoding[J]. Proc Natl Acad Sci USA, 2018, 115(25):E5805-E5814.
doi: 10.1073/pnas.1716750115 |
[18] |
Pak J, Huang F, Li J, et al. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice[J]. Proc Natl Acad Sci USA, 2000, 97(21):11232-11237.
doi: 10.1073/pnas.210184697 |
[19] |
Huang K P, Huang F L, Tino J, et al. Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling[J]. J Neurosci, 2004, 24(47):10660-10669.
doi: 10.1523/JNEUROSCI.2213-04.2004 |
[20] |
Huang F L, Huang K P. Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice[J]. Genes Brain Behav, 2012, 11(7):794-805.
doi: 10.1111/j.1601-183X.2012.00825.x |
[21] |
Zhong L, Brown J, Kramer A, et al. Increased prefrontal cortex neurogranin enhances plasticity and extinction learning[J]. J Neurosci, 2015, 35(19):7503-7508.
doi: 10.1523/JNEUROSCI.0274-15.2015 |
[22] |
Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: current evidence and future directions[J]. Alzheimers Dement, 2016, 12(6):719-732.
doi: 10.1016/j.jalz.2016.02.010 pmid: 27179961 |
[23] |
Esteve C, Jones E, Kell D, et al. Mass spectrometry imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3×Tg Alzheimer mouse model[J]. Biochim Biophys Acta Proteins Proteom, 2017, 1865(7):747-754.
doi: 10.1016/j.bbapap.2017.04.002 |
[24] |
Jeon S, Kang M, Kim Y, et al. Intrahippocampal injection of a lentiviral vector expressing neurogranin enhances cognitive function in 5XFAD mice[J]. Exp Mol Med, 2018, 50(3):e461.
doi: 10.1038/emm.2017.302 |
[25] |
Kaleka K, Gerges N. Neurogranin restores amyloid β-mediated synaptic depression and long-term potentiation deficits[J]. Exp Neurol, 2016, 277:115-123.
doi: 10.1016/j.expneurol.2015.12.013 |
[26] |
Kvartsberg H, Duits F, Ingelsson M, et al. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease[J]. Alzheimers Dement, 2015, 11(10):1180-1190.
doi: 10.1016/j.jalz.2014.10.009 pmid: 25533203 |
[27] |
Headley A, Deleonbenedetti A, Dong C, et al. Neurogranin as a predictor of memory and executive function decline in MCI patients[J]. Neurology, 2018, 90(10):e887-e895.
doi: 10.1212/WNL.0000000000005057 |
[28] |
Kester M, Teunissen C, Crimmins D, et al. Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease[J]. JAMA Neurol, 2015, 72(11):1275-1280.
doi: 10.1001/jamaneurol.2015.1867 |
[29] |
Scheff S, Price D, Ansari M, et al. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease[J]. J Alzheimers Dis, 2015, 43(3):1073-1090.
doi: 10.3233/JAD-141518 |
[30] |
Wellington H, Paterson R, Portelius E, et al. Increased CSF neurogranin concentration is specific to Alzheimer disease[J]. Neurology, 2016, 86(9):829-835.
doi: 10.1212/WNL.0000000000002423 pmid: 26826204 |
[31] | Cesario B, Sandra A, Ike D, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities[J]. Neuropsychiatr Dis Treat, 2015, 11:97-106. |
[32] |
Dong Z, Pan K, Pan J, et al. The possibility and molecular mechanisms of cell pyroptosis after cerebral ischemia[J]. Neurosci Bull, 2018, 34(6):1131-1136.
doi: 10.1007/s12264-018-0294-7 |
[33] |
Vos A, Bjerke M, Brouns R, et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke[J]. BMC Neurol, 2017, 17(1):170-177.
doi: 10.1186/s12883-017-0945-8 |
[34] | 李雨峰, 吴莹, 程明, 等. 康复训练对脑梗死大鼠认知功能、海马内突触素和神经颗粒素表达的影响[J]. 中国康复理论与实践, 2012, 18(1):15-18. |
[35] |
Hemsley D. The development of a cognitive model of schizophrenia: Placing it in context[J]. Neurosci Biobehav Rev, 2005, 29(6):977-988.
doi: 10.1016/j.neubiorev.2004.12.008 |
[36] |
Sudesh R, Thirunavukkarasu P, Rajendran P, et al. Minor allele C of rs12807809 polymorphism in NRGN contributes to the severity of psychosis in patients with Schizophrenia in South Indian population[J]. Neurosci Lett, 2017, 649(1):107-111.
doi: 10.1016/j.neulet.2017.04.008 |
[37] |
Su L, Long J, Pan R, et al. Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China[J]. Acta Neuropsychiatr, 2015, 27(4):221-227.
doi: 10.1017/neu.2015.13 |
[38] |
Wen Z, Chen J, Khan R, et al. Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population[J]. J Affect Disord, 2016, 194(1):180-187.
doi: 10.1016/j.jad.2016.01.034 |
[39] |
Stefansson H, Ophoff R, Steinberg S, et al. Common variants conferring risk of schizophrenia[J]. Nature, 2009, 460(7256):744-747.
doi: 10.1038/nature08186 pmid: 19571808 |
[40] |
Thong J, Qiu A, Min Y, et al. Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia[J]. PLoS One, 2013, 8(12):e85603.
doi: 10.1371/journal.pone.0085603 |
[41] |
Bajada C, Haroon H, Azadbakht H, et al. The tract terminations in the temporal lobe: their location and associated functions[J]. Cortex, 2017, 97(1):277-290.
doi: 10.1016/j.cortex.2016.03.013 |
[42] |
Wolff M, Vann S. The cognitive thalamus as a gateway to mental representations[J]. J Neurosci, 2019, 39(1):3-14.
doi: 10.1523/JNEUROSCI.0479-18.2018 |
[43] |
Wilson C, Gaffan D, Browning P, et al. Functional localization within the prefrontal cortex: missing the forest for the trees?[J]. Trends Neurosci, 2010, 33(12):533-540.
doi: 10.1016/j.tins.2010.08.001 |
[44] |
Humphreys G, Lambon R. Fusion and fission of cognitive functions in the human parietal cortex[J]. Cereb Cortex, 2015, 25(10):3547-3560.
doi: 10.1093/cercor/bhu198 |
[45] |
Krug A, Krach S, Jansen A, et al. The effect of neurogranin on neural correlates of episodic memory encoding and retrieval[J]. Schizophr Bull, 2013, 39(1):141-150.
doi: 10.1093/schbul/sbr076 |
[46] |
Tamminga C, Stan A, Wagner A. The hippocampal formation in schizophrenia[J]. Am J Psychiatry, 2010, 167(10):1178-1193.
doi: 10.1176/appi.ajp.2010.09081187 pmid: 20810471 |
[47] | 许扬扬, 张天宏, 王继军, 等. 精神分裂症患者海马受损导致记忆缺陷的发生机制研究进展[J]. 中国神经精神疾病杂志, 2016, 42(10):633-636. |
[48] |
Zhang Y, Gong X, Yin Z, et al. Association between NRGN gene polymorphism and resting-state hippocampal functional connectivity in schizophrenia[J]. BMC Psychiatry, 2019, 19(1):108-116.
doi: 10.1186/s12888-019-2088-5 |
[49] |
Pohlack S, Nees F, Ruttorf M, et al. Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning[J]. Mol Psychiatry, 2011, 16(11):1072-1073.
doi: 10.1038/mp.2011.66 |
[50] |
Selnes P, Stav A, Johansen K, et al. Impaired synaptic function is linked to cognition in Parkinson's disease[J]. Ann Clin Transl Neurol, 2017, 4(10):700-713.
doi: 10.1002/acn3.2017.4.issue-10 |
[51] |
Bereczki E, Bogstedt A, Hoglund K, et al. Synaptic proteins in CSF relate to Parkinson's disease stage markers[J]. NPJ Parkinsons Dis, 2017, 3(1):7-11.
doi: 10.1038/s41531-017-0008-2 |
[52] |
Bereczki E, Francis P, Howlett D, et al. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia[J]. Alzheimers Dement, 2016, 12(11):1149-1158.
doi: S1552-5260(16)30244-8 pmid: 27224930 |
[53] |
Vos A, Bjerke M, Brouns R, et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke[J]. BMC Neurol, 2017, 17(1):170-177.
doi: 10.1186/s12883-017-0945-8 |
[54] | Winston C, Goetzl E, Akers J, et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile[J]. Alzheimers Dement (Amst), 2016, 3(1):63-72. |
[55] |
Casaletto K, Elahi F, Bettcher B, et al. Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers[J]. Neurology, 2017, 89(17):1782-1788.
doi: 10.1212/WNL.0000000000004569 pmid: 28939668 |
[1] | 邵伟婷, 雷江华. 反应中断再定向干预孤独症谱系障碍儿童刻板语言的效果:Scoping综述[J]. 《中国康复理论与实践》, 2024, 30(1): 10-20. |
[2] | 王航宇, 葛可可, 范永红, 都丽露, 邹敏, 封磊. 基于ICD-11和ICF主动式音乐疗法改善认知障碍老年人认知功能的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 36-43. |
[3] | 闻嘉宁, 金秋艳, 张琦, 李杰, 司琦. 认知参与型身体活动对发展儿童青少年执行功能的效果:基于ICF的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 44-53. |
[4] | 葛可可, 范永红, 王航宇, 都丽露, 李长江, 邹敏. 失眠老年人正念干预健康效益的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 54-60. |
[5] | 张婧雅, 邹敏, 孙宏伟, 孙昌隆, 朱峻同. 听障儿童青少年焦虑或抑郁情绪心理干预效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1004-1011. |
[6] | 王俊宇, 杨永, 袁逊, 谢婷, 庄洁. 高强度间歇训练对健康儿童青少年执行功能效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1012-1020. |
[7] | 魏晓微, 杨剑, 魏春艳. 特殊教育学校孤独症谱系障碍儿童参与适应性瑜伽活动的心理与行为效益的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1021-1028. |
[8] | 杨亚茹, 杨剑. 基于WHO-HPS架构学校身体活动相关健康服务及其健康效益:系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1040-1047. |
[9] | 史佳伟, 李凌宇, 杨浩杰, 王琴潞, 邹海欧. 预康复对全膝关节置换术后患者的有效性:系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1057-1064. |
[10] | 蒋长好, 黄辰, 高晓妍, 戴元富, 赵国明. 神经反馈训练对老年人认知功能效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(8): 903-909. |
[11] | 魏晓微, 杨剑, 魏春艳, 贺启令. 学校环境下适应性体育课程促进智力与发展性残疾儿童心理运动发展的系统综述[J]. 《中国康复理论与实践》, 2023, 29(8): 910-918. |
[12] | 张园, 杨剑. 基于世界卫生组织健康促进学校架构的学校健康服务及效果:Scoping综述[J]. 《中国康复理论与实践》, 2023, 29(7): 791-799. |
[13] | 王少璞, 陈钢. 基于世界卫生组织健康促进学校架构的心理行为健康服务及其健康效益:系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(7): 800-807. |
[14] | 蒋长好, 高晓妍. 短时身体活动对儿童认知功能影响的系统综述[J]. 《中国康复理论与实践》, 2023, 29(6): 667-672. |
[15] | 袁媛, 杨剑. 社区老年人身体活动融合慢性病管理的健康效益:Scoping综述[J]. 《中国康复理论与实践》, 2023, 29(5): 541-550. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||
|